Alarm.com Reports Second Quarter 2017 Results
Aug 08, 2017 20:05 pm UTC| Business
-- SaaS and license revenue of $58.9 million, up 40% year-over-year ---- Total revenue of $86.0 million, up 33% year-over-year ---- GAAP net income of $9.9 million, compared to $1.9 million for the second quarter of 2016...
ChemoCentryx Reports Second Quarter 2017 Financial Results and Recent Highlights
Aug 08, 2017 20:05 pm UTC| Business
-- Pivotal Phase III ADVOCATE trial of avacopan on track to complete enrollment in mid-2018 as projected -- -- Launching second trial of avacopan in patients with C3 Glomerulopathy (C3G) -- -- Conference call today at...
TRACON Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
Aug 08, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 08, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related...
FTD Companies, Inc. Announces Second Quarter 2017 Financial Results
Aug 08, 2017 20:05 pm UTC| Business
Company Updates Full Year 2017 OutlookAnnounces Executive Leadership Changes DOWNERS GROVE, Ill., Aug. 08, 2017 -- FTD Companies, Inc. (Nasdaq:FTD) (“FTD” or the “Company”), a premier floral and gifting company,...
Midland States Bancorp, Inc. Declares Quarterly Cash Dividend of $0.20 Per Share
Aug 08, 2017 20:05 pm UTC| Business
EFFINGHAM, Ill., Aug. 08, 2017 -- Midland States Bancorp, Inc. (NASDAQ:MSBI) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share. The dividend is payable on or about August...
TESARO Announces Second-Quarter 2017 Operating Results
Aug 08, 2017 20:05 pm UTC| Business
ZEJULA is the most prescribed PARP inhibitor in U.S.; Q2 net sales totaled $26 million in first quarter of availabilityRecently opened European niraparib EAP has enrolled 200 patientsVARUBY oral launch now underway in...
Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights
Aug 08, 2017 20:05 pm UTC| Business
Commercial preparations for the potential launch of ZilrettaTM (FX006) advancing rapidlyStudy evaluating the safety of repeat administration of Zilretta has been fully enrolledManagement strengthened with recent...